$BGMS

The Board of Directors of Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable…

Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events . On October 15, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable

Original reporting
Published Oct 16, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$BGMS
Neutral
medium confidence
Mentioned
$BGMS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BGMSNeutralLow
01

Why it matters

The dividend adds a small cash component to the security, likely providing modest price support.

02

Market read

A primary corporate action with limited market impact; relevant mainly to current shareholders.

03

What to watch

Potential tax considerations for preferred shareholders.

Relevance 5/10Novelty 5/10Timing: record date Oct 26, payable Nov 1

Background

SEC Form 8‑K filing reports the company's first dividend declaration for its convertible preferred stock.

Company-level read

Ticker impact

$BGMSNeutralMedium confidence
Context

Board declared a $0.15 per share quarterly cash dividend on 6% Convertible Exchangeable Preferred Stock.

Expected impact

likely slight upward pressure as investors price in the dividend.

Evidence & confidence

Dividends on preferred shares are a small cash benefit; impact is limited given the modest amount.

Market effects

Minimal effect on the broader healthcare sector.

Limited to investors holding BGMS preferred shares.

None

Counterpoint

The dividend may be seen as a signal of limited growth opportunities.

Key entities

  • Bio Green Med Solution, Inc.

    Issuer of the dividend‑paying preferred stock.

Related articles

$BGMSMed

BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update

Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, August 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fi

$BGMSHighAI 9/10

Bio Green Med Solution Surges 172 % After Announcing Deal to Acquire Malaysia Waste Tech Company - Bio Gre

Bio Green Med Solution (NASDAQ:BGMS) shares rose about 123% to $2.35 after it signed an all-stock business combination agreement with Malaysia-based Future NRG. Future NRG will become a wholly owned BGMS subsidiary; the combined firm is expected to trade on Nasdaq under BGMS, led by Datuk Dr. Doris Wong Sing Ee. The deal is expected to close in Q4 2026, pending shareholder approval and SEC registration.